1568 related articles for article (PubMed ID: 3339609)
21. Stereoselective synthesis of 9-hydroxyellipticine glycosides, novel and highly active antitumor agents.
Honda T; Inoue M; Kato M; Shima K; Shimamoto T
Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3975-8. PubMed ID: 3435996
[No Abstract] [Full Text] [Related]
22. Synthesis and evaluation of 9-hydroxy-5-methyl-(and 5,6-dimethyl)-6H-pyrido[4,3-b]carbazole-1-N- [(dialkylamino)alkyl]carboxamides, a new promising series of antitumor olivacine derivatives.
Jasztold-Howorko R; Landras C; Pierré A; Atassi G; Guilbaud N; Kraus-Berthier L; Léonce S; Rolland Y; Prost JF; Bisagni E
J Med Chem; 1994 Jul; 37(15):2445-52. PubMed ID: 8057291
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antitumor activity of 1-[[(dialkylamino)alkyl]amino]-4-methyl-5H-pyrido[4,3-b]benzo[e]- and -benzo[g])indoles. A new class of antineoplastic agents.
Nguyen CH; Lhoste JM; Lavelle F; Bissery MC; Bisagni E
J Med Chem; 1990 May; 33(5):1519-28. PubMed ID: 2329575
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of 11H-pyridocarbazoles and derivatives. Comparison of their DNA binding and antitumor activity with those of 6H- and 7H-pyridocarbazoles.
Lescot E; Muzard G; Markovits J; Belleney J; Roques BP; Le Pecq JB
J Med Chem; 1986 Sep; 29(9):1731-7. PubMed ID: 3746819
[TBL] [Abstract][Full Text] [Related]
25. Potential antitumor agents: synthesis and biological properties of aliphatic amino acid 9-hydroxyellipticinium derivatives.
Auclair C; Voisin E; Banoun H; Paoletti C; Bernadou J; Meunier B
J Med Chem; 1984 Sep; 27(9):1161-6. PubMed ID: 6471070
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of novel heteroaromatics structurally related to ellipticine alkaloids via thermolysis of pyridannulated enyne-carbodiimides.
Lu X; Petersen JL; Wang KK
J Org Chem; 2002 Jul; 67(15):5412-5. PubMed ID: 12126441
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and antitumor activity of quaternary ellipticine glycosides, a series of novel and highly active antitumor agents.
Honda T; Kato M; Inoue M; Shimamoto T; Shima K; Nakanishi T; Yoshida T; Noguchi T
J Med Chem; 1988 Jul; 31(7):1295-305. PubMed ID: 3385725
[TBL] [Abstract][Full Text] [Related]
28. [Pyrido[4,3-b]carbazoles as new cytostatics. Development, chemistry and clinical use].
Pindur U
Pharm Unserer Zeit; 1987 Mar; 16(2):47-52. PubMed ID: 3588647
[No Abstract] [Full Text] [Related]
29. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
[TBL] [Abstract][Full Text] [Related]
30. An alternative way of the synthesis of 1-substituted 9-methoxy-5-methyl-6H-pyrido[4,3-b]carbazole derivatives.
Jasztold-Howorko R; Croisy A; Carrez D
Acta Pol Pharm; 2005; 62(3):207-12. PubMed ID: 16193813
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of amino-substituted benzo[f]pyrido[4,3-b] and pyrido[3,4-b]quinoxalines: a new class of antineoplastic agents.
Nguyen CH; Fan E; Riou JF; Bissery MC; Vrignaud P; Lavelle F; Bisagni E
Anticancer Drug Des; 1995 Jun; 10(4):277-97. PubMed ID: 7786395
[TBL] [Abstract][Full Text] [Related]
32. Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl.
Auclair C; Pierre A; Voisin E; Pepin O; Cros S; Colas C; Saucier JM; Verschuere B; Gros P; Paoletti C
Cancer Res; 1987 Dec; 47(23):6254-61. PubMed ID: 3677074
[TBL] [Abstract][Full Text] [Related]
33. N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines.
Ruckdeschel JC; Modi SP; el-Hamouly W; Portuese E; Archer S
J Med Chem; 1992 Dec; 35(26):4854-7. PubMed ID: 1479585
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological activity of 5-aza-ellipticine derivatives.
Moody DL; Dyba M; Kosakowska-Cholody T; Tarasova NI; Michejda CJ
Bioorg Med Chem Lett; 2007 Apr; 17(8):2380-4. PubMed ID: 17376678
[TBL] [Abstract][Full Text] [Related]
35. 5-(2-aminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: variation of n-alkyl substituents modulates sensitivity to efflux transporters associated with multidrug resistance.
Ruchelman AL; Houghton PJ; Zhou N; Liu A; Liu LF; LaVoie EJ
J Med Chem; 2005 Feb; 48(3):792-804. PubMed ID: 15689163
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
Wang L; Switalska M; Mei ZW; Lu WJ; Takahara Y; Feng XW; El-Sayed Iel-T; Wietrzyk J; Inokuchi T
Bioorg Med Chem; 2012 Aug; 20(15):4820-9. PubMed ID: 22748378
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antitumor activity of quaternary salts of 2-(2'-oxoalkoxy)-9-hydroxyellipticines.
Harada N; Kawaguchi T; Inoue I; Ohashi M; Oda K; Hashiyama T; Tsujihara K
Chem Pharm Bull (Tokyo); 1997 Jan; 45(1):134-7. PubMed ID: 9023975
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo pharmacological characterizations of the antitumor properties of two new olivacine derivatives, S16020-2 and S30972-1.
Malonne H; Farinelle S; Decaestecker C; Gordower L; Fontaine J; Chaminade F; Saucier JM; Atassi G; Kiss R
Clin Cancer Res; 2000 Sep; 6(9):3774-82. PubMed ID: 10999772
[TBL] [Abstract][Full Text] [Related]
39. New pyridocarbazole derivatives. Synthesis and their in vitro anticancer activity.
Jasztold-Howorko R; Tylińska B; Biaduń B; Gebarowski T; Gasiorowski K
Acta Pol Pharm; 2013; 70(5):823-32. PubMed ID: 24147360
[TBL] [Abstract][Full Text] [Related]
40. Antitumor amino-substituted pyrido[3',4':4,5]pyrrolo[2,3-g]isoquinolines and pyrido[4,3-b]carbazole derivatives: synthesis and evaluation of compounds resulting from new side chain and heterocycle modifications.
Rivalle C; Wendling F; Tambourin P; Lhoste JM; Bisagni E; Chermann JC
J Med Chem; 1983 Feb; 26(2):181-5. PubMed ID: 6827534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
